Melanoma can return at or near the original surgical site, a phenomenon doctors call local recurrence. In a large Danish cohort of more than 25,000 melanoma patients, about one in ten developed a recurrence of some kind, and roughly a third of those recurrences were locoregional, meaning they appeared in the skin near the original tumor or in nearby lymph nodes. The biology behind this is more nuanced than most people expect, and the distinction between a true local recurrence, a new primary melanoma, and harmless scar pigmentation is one that even experienced clinicians sometimes struggle with.
How Often Does Melanoma Come Back Locally?
The overall risk of melanoma recurrence depends heavily on the stage of the original tumor. In the Danish national cohort study tracking patients diagnosed between 2008 and 2021, the cumulative incidence of any recurrence climbed steeply with stage. Among all patients who recurred, about a third had locoregional recurrence, while the majority had distant spread to organs like the lungs or brain.1JAMA Dermatology. Stage-Specific Risk of Recurrence and Death From Melanoma in Denmark, 2008-2021 That pattern held across stages, which means local recurrence is not just a problem for people with thick or advanced tumors. Even thin melanomas can come back near the scar, though the absolute numbers are smaller.
For purely local recurrence at the excision site, the rates reported across studies range from under 1% to roughly 9%, depending on the surgical technique used, the thickness of the original melanoma, and how long patients were followed. A meta-analysis pooling data from comparative and noncomparative studies found a local recurrence rate of about 7% after standard wide local excision, 3% after staged excision with margin mapping, and less than 1% after Mohs micrographic surgery.2PubMed. Local Recurrence of Melanoma Is Higher After Wide Local Excision Versus Mohs Micrographic Surgery or Staged Excision Those differences are large enough to matter, and they point to how much the completeness of surgical removal influences what happens later.
What Makes a Local Recurrence More Likely?
Several features of the original melanoma raise the odds that tumor cells were left behind or had already begun spreading microscopically before surgery. The thickness of the tumor, measured in millimeters, is the single most consistent predictor across studies. Thicker melanomas have had more time to grow deeper into the skin and to shed cells into surrounding tissue and lymphatics. In one study of patients with melanomas thicker than 2 mm at difficult anatomic sites, Breslow thickness was the only factor that reached statistical significance for predicting local recurrence.3Journal of the National Comprehensive Cancer Network. Local Recurrence and Survival in Patients With Melanoma >2 mm in Thickness at Difficult Sites Treated With 1-cm Versus 2-cm Margins
Beyond thickness, other tumor characteristics associated with worse outcomes include ulceration on the surface of the melanoma, a high mitotic rate (how quickly the cancer cells were dividing), and lymphovascular invasion, where tumor cells are found inside blood vessels or lymph channels in the biopsy specimen.4PubMed Central. Invasive Cutaneous Melanoma: Evaluating the Prognostic Significance of Some Parameters Associated with Lymph Node Metastases A study of high-risk primary melanomas found that within two years of diagnosis, about 13% of patients developed at least one recurrence, and the factors most strongly linked to that two-year recurrence were ulceration, a mitotic rate above three per square millimeter, and more advanced clinical stage.5JAMA Dermatology. Risk of Melanoma Recurrence After Diagnosis of a High-Risk Primary Tumor
Location matters too. Melanomas on the head and neck, fingers, toes, and other sites where there is little tissue to spare are harder to excise with generous margins, and the local recurrence rates at these sites tend to be higher than on the trunk or limbs. Acral melanomas, the type found on the palms, soles, and under nails, have their own recurrence pattern. In one study of acral melanoma patients, about a third developed metastasis during follow-up, and the most common type was locoregional recurrence.6Scientific Reports. Acral malignant melanoma; emphasis on the primary metastasis and the usefulness of preoperative ultrasound for sentinel lymph node metastasis
How Surgical Margins Influence the Risk
When surgeons remove a melanoma, they take a margin of normal-looking skin around it. The rationale is straightforward: melanoma cells can extend beyond the visible border of the tumor, and a wider margin is supposed to catch those invisible extensions. For decades, the standard has been to scale the margin to the thickness of the tumor, typically 1 cm for thinner melanomas and 2 cm for thicker ones.
What the research shows, though, is that the margin width matters less than most people assume. A systematic review and meta-analysis comparing narrow margins (1 to 2 cm) with wide margins (3 to 5 cm) found no statistically significant difference in local recurrence, regional lymph node spread, distant metastasis, or death from melanoma.7PubMed. Surgical excision margins in primary cutaneous melanoma: A systematic review and meta-analysis For very thin melanomas (T1a, under 0.8 mm without ulceration), even margins as small as 5 mm appear to produce comparable local recurrence rates to wider excisions. A study of T1a melanomas at critical structures found a 10-year local recurrence rate of about 6% to 7% regardless of whether a narrow or wide margin was used.8PubMed Central. Association of Excision Margin Size With Local Recurrence and Survival in Patients With T1a Melanoma at Critical Structures
This does not mean margins are irrelevant. It means that the difference between 1 cm and 2 cm is smaller than the difference between a complete excision and an incomplete one. What matters more than the numerical margin is whether the surgical specimen comes back with truly clear pathologic margins, meaning the pathologist confirms no tumor cells at the cut edge.
Why Surgical Technique Can Matter More Than Margin Width
Standard wide local excision involves removing the melanoma with a margin and then sending the tissue to a pathologist who examines thin slices from representative spots. The limitation is that this bread-loaf sectioning method examines only a tiny fraction of the actual margin, sometimes as little as 1% to 2% of the cut edge. Melanoma cells hiding in the portions not examined will be missed.
Mohs micrographic surgery and staged excision techniques take a different approach. They map and examine 100% of the peripheral and deep margins, which means residual tumor cells are far less likely to escape detection. The difference in outcomes is striking. Pooled data from a systematic review showed that local recurrence after Mohs surgery was less than 1%, compared with 7% after standard wide local excision, with the odds of recurrence roughly 3.3 times higher after wide excision than after Mohs.2PubMed. Local Recurrence of Melanoma Is Higher After Wide Local Excision Versus Mohs Micrographic Surgery or Staged Excision These margin-controlled techniques are especially valuable on the face and other areas where tissue conservation matters, and they are frequently used for melanoma in situ and lentigo maligna, a subtype notorious for having invisible extensions well beyond the clinical border.
Speaking of lentigo maligna, a study comparing margins needed for lentigo maligna versus other subtypes of melanoma in situ found that both required a 12 mm margin on the head and neck and a 9 mm margin on the trunk and extremities to achieve a 97% clearance rate. A standard 6 mm margin cleared only about 79% to 83% of cases.9PubMed. Comparison of surgical margins for lentigo maligna versus melanoma in situ This is a surprisingly high failure rate for what is technically a “pre-invasive” form of melanoma, and it helps explain why lentigo maligna is one of the subtypes that recurs locally most often.
Telling Recurrence Apart from Harmless Scar Changes
One of the most anxiety-producing experiences after melanoma surgery is noticing pigmentation developing in or around the scar. Not every dark spot near a melanoma scar is cancer. Scars can develop benign pigment from sun exposure, from the body’s normal healing process, or from a benign proliferation of melanocytes that repopulate the scar tissue. Tattoo pigment from surgical marking, bruising, and post-inflammatory changes can all mimic something more concerning.
The challenge is real even for dermatologists. Standard dermoscopy, the magnified examination of skin lesions with a handheld instrument, picks up recurrent lentigo maligna only about 29% of the time using the classic criteria specific to that diagnosis. That is because recurrences in scars often look different from primary tumors: they tend to present as subtle, flat, light-brown patches rather than the dark, asymmetric lesions most people picture when they think of melanoma. A study evaluating advanced imaging found that the most common dermoscopic feature in recurrent lentigo maligna was a homogeneous or structureless area of light-brown pigmentation, present in about 93% of recurrences but also seen in about 38% of benign cases.10PubMed Central. Reflectance confocal microscopy and dermoscopy aid in evaluating repigmentation within or adjacent to lentigo maligna melanoma surgical scars More advanced technology like reflectance confocal microscopy, which visualizes skin cells in real time without a biopsy, achieved about 90% diagnostic accuracy in distinguishing true recurrences from lookalikes. When there is any doubt, a biopsy remains the definitive answer.
Late Recurrence and Tumor Dormancy
Most melanoma recurrences show up within the first two to three years after surgery. But melanoma is unusual among cancers in its ability to reappear many years or even decades later. Cases of recurrence 10, 15, and even 25 years after treatment are documented in the medical literature, and they are not just statistical outliers.
The explanation involves tumor dormancy, a state in which microscopic clusters of melanoma cells survive in the body but are held in check, neither growing nor dying, for years. These dormant cells can lodge in the original tumor bed, in nearby lymph nodes, or at distant sites. What eventually tips them from dormancy into active growth remains poorly understood, but the immune system appears to play a central role. As long as the immune system keeps the dormant cells suppressed, nothing happens. If that balance shifts due to aging, immune suppression, or some other trigger, dormant cells can begin proliferating again.11PubMed Central. Late Recurrence in Melanoma: Clinical Implications of Lost Dormancy
This is why melanoma follow-up does not have a clean endpoint. Unlike many cancers where five years disease-free is considered essentially cured, melanoma patients are typically followed for at least ten years, and many guidelines recommend lifelong skin surveillance. The possibility of late recurrence is also a reason that any new or changing pigmented lesion near a melanoma scar should be taken seriously, no matter how many years have passed.
A New Primary Melanoma Is Not the Same as Recurrence
There is an important distinction between melanoma recurring from residual cells of the original tumor and developing an entirely new, unrelated melanoma. People who have had melanoma are at substantially increased risk of developing a second primary melanoma, and this new tumor can appear anywhere on the body, including near the original site. A study of more than 89,000 melanoma patients found that the risk of developing a subsequent primary melanoma was over eight times higher than expected in the general population. Women who had melanoma on the head and neck and patients younger than 30 had even higher risks, with observed-to-expected ratios above 13.12PubMed Central. Increased risk of second primary cancers after a diagnosis of melanoma
This matters because a second primary melanoma near the old scar can easily be mistaken for a recurrence, and the two have different implications. A true local recurrence is typically staged and treated based on the characteristics of the original tumor, since it is biologically the same cancer. A new primary melanoma is staged independently, and it is often thinner at diagnosis than the first melanoma because these patients are usually under close surveillance. In the study cited above, second melanomas were more likely to be thin (under 1 mm) than first melanomas.12PubMed Central. Increased risk of second primary cancers after a diagnosis of melanoma The practical upside is that close follow-up catches new tumors early, when they are most curable.
What Happens If Melanoma Does Recur Locally
When a true local recurrence is confirmed by biopsy, the approach mirrors the treatment of a primary melanoma with comparable characteristics. Wide re-excision is performed using margin guidelines based on the original tumor’s thickness and stage. Depending on the circumstances, sentinel lymph node biopsy and adjuvant therapy may be reconsidered.13PubMed Central. Surviving Cutaneous Melanoma: A Clinical Review of Follow-up Practices, Surveillance, and Management of Recurrence The prognosis after a local recurrence is generally worse than after initial treatment, not because local disease is inherently fatal, but because local recurrence is a signal that the melanoma had more aggressive biology than initially apparent and may have spread elsewhere.
For patients already on or considering adjuvant immunotherapy (checkpoint inhibitors like nivolumab or pembrolizumab), the relationship between immunotherapy and local recurrence patterns is an area of active research. One multi-institutional study noted a trend toward higher rates of local recurrence among patients who started adjuvant immunotherapy within six weeks of surgery compared to those who started later, though the numbers were not definitive.14PubMed Central. Timing of Adjuvant Immunotherapy in Stage III Melanoma, Does it Matter? The broader evidence supports adjuvant immunotherapy for reducing overall recurrence risk in stage III melanoma, but the optimal timing and its effect specifically on local versus distant recurrence remain topics of ongoing study.
How Surveillance Works After Melanoma Surgery
Follow-up after melanoma surgery is designed around the fact that the surgical scar and the surrounding skin are the first places a local recurrence will appear. A scoping review of melanoma follow-up guidelines from around the world found that while specifics varied, the common threads were examination of the entire skin surface, specific examination of the surgical scar, and palpation of the regional lymph node basins. Most guidelines recommended some form of self-skin examination, with recommended frequency ranging from monthly to annually depending on the guideline.15PubMed Central. Surveillance After a Previous Cutaneous Melanoma Diagnosis: A Scoping Review of Melanoma Follow-Up Guidelines
Some centers have begun incorporating ultrasound of the excision scar into routine follow-up, particularly for higher-risk patients. One institutional protocol used high-frequency ultrasound to examine the scar every three months for the first two years after surgery, then every six months from years three to five.16PubMed Central. Ultra-High-Frequency Ultrasound of Melanoma Excision Scars for Detection of Clinically Occult Local Recurrence This kind of imaging can detect subclinical recurrences, meaning ones not yet visible on the skin surface, potentially allowing treatment before the recurrence becomes more advanced. The technology is not yet standard everywhere, but it reflects a growing recognition that detecting local recurrence early improves outcomes.
At home, the practical advice is straightforward. Get to know your scar. Look at it regularly in good light. Any new lump, nodule, or pigmented patch in or near the scar warrants a visit to your dermatologist, even if it looks small or subtle. The same applies to any new mole or changing spot anywhere on your body, since your risk of developing additional melanomas is elevated.
The Psychological Weight of Watching Your Scar
It is worth acknowledging that the constant vigilance melanoma survivors are asked to maintain takes a real psychological toll. A qualitative study of localized cutaneous melanoma survivors found that nearly three-quarters of participants scored above the clinical threshold for fear of cancer recurrence. Interviews revealed recurring themes of anxiety around follow-up appointments, hyper-vigilance during skin self-exams, significant lifestyle changes around sun exposure, and intrusive thoughts about mortality.17PubMed Central. Lived Experiences and Fear of Cancer Recurrence Among Survivors of Localized Cutaneous Melanoma
This fear is not irrational. Melanoma is a cancer that can come back, including at the same spot, and the uncertainty extends for years. But the fear can become disproportionate to the actual risk, particularly for people with early-stage disease where the statistical likelihood of recurrence is low. If checking your scar has become a source of daily distress rather than a monthly routine, that is worth discussing with your care team. Screening programs for fear of cancer recurrence exist, and targeted psychological interventions have been shown to reduce the severity of these symptoms in cancer survivors more broadly. The goal is not to stop paying attention to your skin but to find a sustainable level of vigilance that does not erode your quality of life.